A New Class of Medicines through DNA Editing

Therapeutic editing of the human genome has long been a holy grail of genetic medicine. Different approaches are founded on a bedrock of basic laboratory discovery. Podcast describes the history, applications, and limitations of genome editing for clinical application. Matthew H. Porteus, the interviewee, is professor of pediatrics–stem cell transplantation at Stanford University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the New England Journal of Medicine.

Click the image below to access the Podcast.

Follow Us
  • Facebook Classic
  • Twitter Classic
  • YouTube Classic
  • Google Classic
RSS Feed
Featured Posts
Recent Posts